61 related articles for article (PubMed ID: 19672874)
21. DBC1 is over-expressed and associated with poor prognosis in colorectal cancer.
Zhang Y; Gu Y; Sha S; Kong X; Zhu H; Xu B; Li Y; Wu K
Int J Clin Oncol; 2014 Feb; 19(1):106-12. PubMed ID: 23299276
[TBL] [Abstract][Full Text] [Related]
22. Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletion.
Sengupta N; Yau C; Sakthianandeswaren A; Mouradov D; Gibbs P; Suraweera N; Cazier JB; Polanco-Echeverry G; Ghosh A; Thaha M; Ahmed S; Feakins R; Propper D; Dorudi S; Sieber O; Silver A; Lai C
Mol Cancer; 2013 Jan; 12():1. PubMed ID: 23286373
[TBL] [Abstract][Full Text] [Related]
23. Use of multivariate analysis to suggest a new molecular classification of colorectal cancer.
Domingo E; Ramamoorthy R; Oukrif D; Rosmarin D; Presz M; Wang H; Pulker H; Lockstone H; Hveem T; Cranston T; Danielsen H; Novelli M; Davidson B; Xu ZZ; Molloy P; Johnstone E; Holmes C; Midgley R; Kerr D; Sieber O; Tomlinson I
J Pathol; 2013 Feb; 229(3):441-8. PubMed ID: 23165447
[TBL] [Abstract][Full Text] [Related]
24. DBC1 does not function as a negative regulator of SIRT1 in liver cancer.
Bae HJ; Chang YG; Noh JH; Kim JK; Eun JW; Jung KH; Kim MG; Shen Q; Ahn YM; Kwon SH; Park WS; Lee JY; Nam SW
Oncol Lett; 2012 Nov; 4(5):873-877. PubMed ID: 23162614
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations.
Xie T; D' Ario G; Lamb JR; Martin E; Wang K; Tejpar S; Delorenzi M; Bosman FT; Roth AD; Yan P; Bougel S; Di Narzo AF; Popovici V; Budinská E; Mao M; Weinrich SL; Rejto PA; Hodgson JG
PLoS One; 2012; 7(7):e42001. PubMed ID: 22860045
[TBL] [Abstract][Full Text] [Related]
26. A review of spatial computational models for multi-cellular systems, with regard to intestinal crypts and colorectal cancer development.
De Matteis G; Graudenzi A; Antoniotti M
J Math Biol; 2013 Jun; 66(7):1409-62. PubMed ID: 22565629
[TBL] [Abstract][Full Text] [Related]
27. A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment.
Jasmine F; Rahaman R; Dodsworth C; Roy S; Paul R; Raza M; Paul-Brutus R; Kamal M; Ahsan H; Kibriya MG
PLoS One; 2012; 7(2):e31968. PubMed ID: 22363777
[TBL] [Abstract][Full Text] [Related]
28. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.
Singh A; Sweeney MF; Yu M; Burger A; Greninger P; Benes C; Haber DA; Settleman J
Cell; 2012 Feb; 148(4):639-50. PubMed ID: 22341439
[TBL] [Abstract][Full Text] [Related]
29. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.
Imajo M; Miyatake K; Iimura A; Miyamoto A; Nishida E
EMBO J; 2012 Mar; 31(5):1109-22. PubMed ID: 22234184
[TBL] [Abstract][Full Text] [Related]
30. EMT is the dominant program in human colon cancer.
Loboda A; Nebozhyn MV; Watters JW; Buser CA; Shaw PM; Huang PS; Van't Veer L; Tollenaar RA; Jackson DB; Agrawal D; Dai H; Yeatman TJ
BMC Med Genomics; 2011 Jan; 4():9. PubMed ID: 21251323
[TBL] [Abstract][Full Text] [Related]
31. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.
Poulogiannis G; McIntyre RE; Dimitriadi M; Apps JR; Wilson CH; Ichimura K; Luo F; Cantley LC; Wyllie AH; Adams DJ; Arends MJ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15145-50. PubMed ID: 20696900
[TBL] [Abstract][Full Text] [Related]
32. Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.
Malhotra P; Anwar M; Nanda N; Kochhar R; Wig JD; Vaiphei K; Mahmood S
Tumour Biol; 2013 Jun; 34(3):1901-11. PubMed ID: 23526092
[TBL] [Abstract][Full Text] [Related]
33. Genetic alterations in locally advanced stage II/III colon cancer: a search for prognostic markers.
Westra JL; Plukker JT; Buys CH; Hofstra RM
Clin Colorectal Cancer; 2004 Nov; 4(4):252-9. PubMed ID: 15555207
[TBL] [Abstract][Full Text] [Related]
34. Mutant p53 in colon cancer.
Nakayama M; Oshima M
J Mol Cell Biol; 2019 Apr; 11(4):267-276. PubMed ID: 30496442
[TBL] [Abstract][Full Text] [Related]
35. Integrative approach for prioritizing cancer genes in sporadic colon cancer.
Reid JF; Gariboldi M; Sokolova V; Capobianco P; Lampis A; Perrone F; Signoroni S; Costa A; Leo E; Pilotti S; Pierotti MA
Genes Chromosomes Cancer; 2009 Nov; 48(11):953-62. PubMed ID: 19672874
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.
Palacio-Rúa KA; Isaza-Jiménez LF; Ahumada-Rodríguez E; Muñetón-Peña CM
Rev Gastroenterol Mex; 2014; 79(2):79-89. PubMed ID: 24861525
[TBL] [Abstract][Full Text] [Related]
37. Copy number of the Adenomatous Polyposis Coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene.
Zauber P; Marotta S; Sabbath-Solitare M
BMC Cancer; 2016 Mar; 16():213. PubMed ID: 26970738
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
